We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CorMedix Inc | AMEX:CRMD | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.90 | 0 | 01:00:00 |
☐
|
Preliminary Proxy Statement.
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2)).
|
☐
|
Definitive Proxy Statement.
|
☒
|
Definitive Additional Materials.
|
☒
|
No fee required.
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
Title of each class of securities to which transaction
applies:
|
☐
|
Fee paid previously with preliminary materials.
|
☐
|
Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
|
CORMEDIX INC.
|
CONTROL ID:
|
|
||||
REQUEST ID:
|
|
|||||
|
||||||
IMPORTANT NOTICE
REGARDING THE AVAILABILITY OF PROXY MATERIALS
for the Annual Meeting of
Stockholders
|
||||||
|
DATE:
|
JUNE 6, 2017
|
||||
|
TIME:
|
11:00 a.m. Eastern time
|
||||
|
LOCATION:
|
1545 U.S. Highway 206, First Floor Conference Room, Bedminster, New
Jersey
|
This is not a ballot. You cannot
use this notice to vote your shares. This communication represents
a notice to access a more complete set of proxy materials available
to you on the Internet. We encourage you to access and review all
of the important information contained in the proxy materials
before voting. The proxy statement is available at:
https://www.iproxydirect.com/CRMD
|
|
The purposes of this meeting are as follows:
|
|
||||
1.
|
1.
To elect six directors to serve until the 2018 Annual Meeting of
Stockholders or until their successors are duly elected and
qualified;
2.
To approve an amendment to our Amended and Restated Certificate of
Incorporation to increase the number of authorized shares of
capital stock from 82,000,000 shares to 202,000,000 shares and to
increase the number of authorized shares of common stock from
80,000,000 shares to 200,000,000 shares;
3.
To Ratify the appointment of Friedman LLP as our independent
registered public accounting firm for the fiscal year ending
December 31, 2017; and
4.
To act upon such other matters as may properly come before the
meeting or any adjournment thereof.
|
|
Pursuant to Securities and Exchange Commission rules, you are
receiving this Notice that the proxy materials for the Annual
Meeting are available on the Internet. Follow the instructions
above to view the materials and vote or request printed
copies.
The board of directors has fixed the close of business on April 13,
2017 as the record date for the determination of stockholders
entitled to receive notice of the Annual Meeting and to vote the
shares of our common stock, par value $.001 per share, they held on
that date at the meeting or any postponement or adjournment of the
meeting.
|
||||||
The Board of Directors recommends that you vote ‘for’
all proposals above.
|
||||||
|
||||||
Please note - This is not a Proxy Card - you cannot vote by
returning this card
|
1 Year CorMedix Chart |
1 Month CorMedix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions